Medical Condition News

RSS

New pre-clinical research shows utility of mRNA platform to treat rare metabolic disorders

An mRNA platform that can express therapeutic levels of protein in liver tissue could be used to treat patients with rare metabolic disorders.

9 Oct 2018

'Supercharged' immune cells could help fight cancer

A type of 'supercharged' immune cell could be mass-produced to help fight cancer.

9 Oct 2018

PolyU develops multi-function nighttime monitoring system for elderly with dementia

The Hong Kong Polytechnic University has developed eNightLog, a multi-function nighttime monitoring system for elderly with dementia, to track their respiration and activities in bed for preventing fall or wandering away.

9 Oct 2018

King's College researchers awarded £2.3 million for new trial to treat liver disease

Dr Mark McPhail from the Department of Inflammation Biology, School of Immunology & Microbial Sciences and Dr Vishal Patel from the Institute of Liver Studies at King's College Hospital have been awarded £2.3 million by the National Institute of Health Research Health Technology Assessment to lead a new UK wide multi-centre trial to treat liver disease.

9 Oct 2018

CDx Diagnostics announces WATS3D data demonstrating crypt dysplasia as risk factor for esophageal cancer

CDx Diagnostics, an innovator in computer synthesized, three dimensional tissue analysis for the early detection and surveillance of Barrett’s esophagus, today announced new data for WATS3D, or Wide Area Transepithelial Sampling with 3D Tissue Analysis, demonstrating the clinical significance of crypt dysplasia as an important risk factor for progression to high-grade esophageal dysplasia or esophageal cancer.

9 Oct 2018

Study links poor manganese uptake to scoliosis

Some cases of severe scoliosis may arise as a result of the body being unable to fully utilize manganese, a dietary mineral used for bone and cartilage growth.

9 Oct 2018

Two related enzymes have opposing roles in heart failure

Two related enzymes have opposing roles in mouse heart muscle cells exposed to pressure overload, according to a recent study published in the Proceedings of the National Academy of Sciences, USA.

9 Oct 2018

Study links scoliosis to essential dietary mineral

Nobody knows why some children's backs start to curve to one side just as they hit puberty. Most children diagnosed with scoliosis, or curvature of the spine, have no known risk factors.

9 Oct 2018

Survey: 2.5 million people experience back pain every day in the UK

One in five people who suffer from back pain have given up their job or reduced their hours because of their condition.

From medserena 9 Oct 2018

Liva Healthcare appoints Dr Roger Henderson to tackle Type 2 diabetes

Liva Healthcare, the digital health platform designed to tackle Type 2 diabetes, has appointed Dr Roger Henderson as UK medical director.

From Liva Healthcare UK 9 Oct 2018

New report reveals concerning inadequacies in care for diabetes inpatients

Diabetes UK’s ‘Making Hospitals Safe for People with Diabetes’ report, released today (08/10/2018), has revealed concerning inadequacies in care for diabetes inpatients.

9 Oct 2018

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Veracyte, Inc. announced the presentation of data demonstrating that the Envisia Genomic Classifier can help physicians more confidently diagnose interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), without the need for surgery.

8 Oct 2018

Genetic link to erectile dysfunction discovered

According to a new study there may be a genetic link to erectile dysfunction. This is the first time that such as connection has been made and this could mean that newer avenues of treatment could be explored for erectile dysfunction, explain the researchers.

8 Oct 2018

Arcus Biosciences announces presentation of final results from Phase 1 study of AB928 at ESMO 2018

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced that it will present final results from the Phase 1 study of AB928, its dual adenosine receptor antagonist, in healthy volunteers during a poster display session at the European Society of Medical Oncology 2018 Congress, being held October 19-23, 2018, in Munich, Germany.

8 Oct 2018

PTSD among army veterans on the rise finds study

A new study has found that there is a rise of post-traumatic-stress disorder (PTSD) among those who have served the army and military over the past decade. The study reveals that most of the personnel who have been witness to active combat were among those who reported with symptoms of PTSD and 17 percent of these individuals were diagnosed with PTSD.

8 Oct 2018

Brexit will seriously harm UK cancer research, experts say

Cancer experts warn that Brexit will seriously harm UK cancer research and could trigger a manpower crisis that will negatively affect the health of our citizens.

8 Oct 2018

Cutting-edge precision medicine spreading from specialist cancer units to community setting

Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network centers in the US, are receiving innovative drugs matched to DNA mutations in their tumors.

8 Oct 2018

Study suggests novel approach to treating adults with autism spectrum disorder

A team of scientists at Florida Atlantic University has uncovered a brain-signaling pathway that can be pharmacologically manipulated in genetically engineered mice to reverse an autism-related pathway.

8 Oct 2018

Study finds suboptimal antithrombotic care in AFib patients with cancer history

Atrial fibrillation patients with a history of cancer are less likely to see a cardiologist or fill anticoagulant prescriptions compared with AFib patients who never had cancer, according to a study in the Journal of the American College of Cardiology.

8 Oct 2018

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with high-risk stage 3 melanoma, with nearly half having no sign of disease at surgery, but a high incidence of side effects caused the trial to be closed early.

8 Oct 2018

Medical Condition News

New pre-clinical research shows utility of mRNA platform to treat rare metabolic disorders

'Supercharged' immune cells could help fight cancer

PolyU develops multi-function nighttime monitoring system for elderly with dementia

King's College researchers awarded £2.3 million for new trial to treat liver disease

CDx Diagnostics announces WATS3D data demonstrating crypt dysplasia as risk factor for esophageal cancer

Study links poor manganese uptake to scoliosis

Two related enzymes have opposing roles in heart failure

Study links scoliosis to essential dietary mineral

Survey: 2.5 million people experience back pain every day in the UK

Liva Healthcare appoints Dr Roger Henderson to tackle Type 2 diabetes

New report reveals concerning inadequacies in care for diabetes inpatients

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Genetic link to erectile dysfunction discovered

Arcus Biosciences announces presentation of final results from Phase 1 study of AB928 at ESMO 2018

PTSD among army veterans on the rise finds study

Brexit will seriously harm UK cancer research, experts say

Cutting-edge precision medicine spreading from specialist cancer units to community setting

Study suggests novel approach to treating adults with autism spectrum disorder

Study finds suboptimal antithrombotic care in AFib patients with cancer history

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News